121 related articles for article (PubMed ID: 37793216)
21. Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer.
Ogobuiro I; Baca Y; Ribeiro JR; Walker P; Wilson GC; Gulhati P; Marshall JL; Shroff RT; Spetzler D; Oberley MJ; Abbott DE; Kim HJ; Kooby DA; Maithel SK; Ahmad SA; Merchant NB; Xiu J; Hosein PJ; Datta J
JCO Precis Oncol; 2023 Sep; 7():e2300152. PubMed ID: 37944072
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
McWilliams RR; Maisonneuve P; Bamlet WR; Petersen GM; Li D; Risch HA; Yu H; Fontham ET; Luckett B; Bosetti C; Negri E; La Vecchia C; Talamini R; Bueno de Mesquita HB; Bracci P; Gallinger S; Neale RE; Lowenfels AB
Pancreas; 2016 Feb; 45(2):311-6. PubMed ID: 26646264
[TBL] [Abstract][Full Text] [Related]
23. Early onset pancreatic cancer: a controlled trial.
Tingstedt B; Weitkämper C; Andersson R
Ann Gastroenterol; 2011; 24(3):206-212. PubMed ID: 24713777
[TBL] [Abstract][Full Text] [Related]
24. Genetic and non-genetic risk factors for early-onset pancreatic cancer.
Nodari Y; Gentiluomo M; Mohelnikova-Duchonova B; Kreivenaite E; Milanetto AC; Skieceviciene J; Landi S; Lawlor RT; Petrone MC; Arcidiacono PG; Lovecek M; Gazouli M; Bijlsma MF; Morelli L; Kiudelis V; Tacelli M; Zanette DL; Soucek P; Uzunoglu F; Kaaks R; Izbicki J; Boggi U; Pezzilli R; Mambrini A; Pasquali C; van Laarhoven HW; Katzke V; Cavestro GM; Sperti C; Loos M; Latiano A; Erőss B; Oliverius M; Johnson T; Basso D; Neoptolemos JP; Aoki MN; Greenhalf W; Vodicka P; Archibugi L; Vanella G; Lucchesi M; Talar-Wojnarowska R; Jamroziak K; Saeedi MA; van Eijck CHJ; Kupcinskas J; Hussein T; Puzzono M; Bunduc S; Götz M; Carrara S; Szentesi A; Tavano F; Moz S; Hegyi P; Luchini C; Capurso G; Perri F; Ermini S; Theodoropoulos G; Capretti G; Palmieri O; Ginocchi L; Furbetta N; Canzian F; Campa D
Dig Liver Dis; 2023 Oct; 55(10):1417-1425. PubMed ID: 36973108
[TBL] [Abstract][Full Text] [Related]
25. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
[TBL] [Abstract][Full Text] [Related]
26. Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study.
Leonhardt CS; Kinny-Köster B; Hank T; Habib JR; Shoucair S; Klaiber U; Cameron JL; Hackert T; Wolfgang CL; Büchler MW; He J; Strobel O
Ann Surg Oncol; 2023 Apr; 30(4):2433-2443. PubMed ID: 36479659
[TBL] [Abstract][Full Text] [Related]
27. Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience.
Repetto M; Crimini E; Boscolo Bielo L; Guerini-Rocco E; Ascione L; Bonfanti A; Zanzottera C; Mazzarella L; Ranghiero A; Belli C; Criscitiello C; Esposito A; Barberis MCP; Curigliano G
Eur J Cancer; 2023 Apr; 183():79-89. PubMed ID: 36801623
[TBL] [Abstract][Full Text] [Related]
28. Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
Pishvaian MJ; Bender RJ; Halverson D; Rahib L; Hendifar AE; Mikhail S; Chung V; Picozzi VJ; Sohal D; Blais EM; Mason K; Lyons EE; Matrisian LM; Brody JR; Madhavan S; Petricoin EF
Clin Cancer Res; 2018 Oct; 24(20):5018-5027. PubMed ID: 29954777
[No Abstract] [Full Text] [Related]
29. Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer.
Ogobuiro I; Baca Y; Ribeiro JR; Walker P; Wilson GC; Gulhati P; Marshall JL; Shroff RT; Spetzler D; Oberley MJ; Abbott DE; Kim HJ; Kooby DA; Maithel SK; Ahmad SA; Merchant NB; Xiu J; Hosein PJ; Datta J
medRxiv; 2023 Mar; ():. PubMed ID: 37034762
[TBL] [Abstract][Full Text] [Related]
30. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract][Full Text] [Related]
31. Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
Martin-Romano P; Mezquita L; Hollebecque A; Lacroix L; Rouleau E; Gazzah A; Bahleda R; Planchard D; Varga A; Baldini C; Postel-Vinay S; Friboulet L; Loriot Y; Verlingue L; Geraud A; Camus MN; Nicotra C; Soria JC; André F; Besse B; Massard C; Italiano A
JCO Precis Oncol; 2022 Oct; 6():e2100484. PubMed ID: 36315916
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
33. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich
Dorman K; Zhang D; Heinrich K; Reeh L; Weiss L; Haas M; Beyer G; Rössler D; Goni E; Renz BW; D'Haese JG; Kunz WG; Seidensticker M; Corradini S; Niyazi M; Ormanns S; Kumbrink J; Jung A; Klauschen F; Werner J; Mayerle J; von Bergwelt-Baildon M; Boeck S; Heinemann V; Westphalen CB
Target Oncol; 2023 Mar; 18(2):257-267. PubMed ID: 36853374
[TBL] [Abstract][Full Text] [Related]
34. ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma.
Verdaguer H; Saurí T; Acosta DA; Guardiola M; Sierra A; Hernando J; Nuciforo P; Miquel JM; Molero C; Peiró S; Serra-Camprubí Q; Villacampa G; Aguilar S; Vivancos A; Tabernero J; Dienstmann R; Macarulla T
Clin Cancer Res; 2022 Apr; 28(8):1662-1671. PubMed ID: 35042699
[TBL] [Abstract][Full Text] [Related]
35. Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer.
LaPelusa M; Shen C; Arhin ND; Cardin D; Tan M; Idrees K; Geevarghese S; Chakravarthy B; Berlin J; Eng C
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053447
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.
Moreira A; Masliah-Planchon J; Callens C; Vacher S; Lecerf C; Frelaut M; Borcoman E; Torossian N; Ricci F; Hescot S; Sablin MP; Tresca P; Loirat D; Melaabi S; Trabelsi-Grati O; Pierron G; Gentien D; Bernard V; Vincent Salomon A; Servant N; Bieche I; Le Tourneau C; Kamal M
Eur J Cancer; 2019 Nov; 121():202-209. PubMed ID: 31593830
[TBL] [Abstract][Full Text] [Related]
37. Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in
Fusco MJ; Saeed-Vafa D; Carballido EM; Boyle TA; Malafa M; Blue KL; Teer JK; Walko CM; McLeod HL; Hicks JK; Extermann M; Fleming JB; Knepper TC; Kim DW
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250383
[TBL] [Abstract][Full Text] [Related]
38. Predictors of Survival among Early Onset Pancreatic Adenocarcinoma Patients A Tertiary Care Center Experience.
Alkashash AM; Elsebaie MA; Bikhet MH; Morsi M; Paluri RK
Chirurgia (Bucur); 2021; 116(1):24-33. PubMed ID: 33638323
[TBL] [Abstract][Full Text] [Related]
39. Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients.
Halder R; Veeravelli S; Cheng C; Estrada-Mendizabal RJ; Recio-Boiles A
J Racial Ethn Health Disparities; 2023 Dec; 10(6):3131-3139. PubMed ID: 37071331
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi F; Stättner S; Schlick K; Kiesslich T; Mayr C; Klieser E; Urbas R; Neureiter D
Onco Targets Ther; 2019; 12():3387-3400. PubMed ID: 31118690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
